Ratevosian, J., Millett, G., Honermann, B., Bennett, S., Connor, C., Bekker, L.-G., & Beyrer, C. (2025). PEPFAR under review: what's at stake for PEPFAR's future. Lancet, 405(10479), 603–605. https://doi.org/10.1016/S0140-6736(25)00258-2

Ratevosian, Jirair, Gregorio Millett, Brian Honermann, Sara Bennett, Catherine Connor, Linda-Gail Bekker, and Chris Beyrer. “PEPFAR under review: what's at stake for PEPFAR's future.” Lancet 405, no. 10479 (February 22, 2025): 603–5. https://doi.org/10.1016/S0140-6736(25)00258-2.

Ratevosian J, Millett G, Honermann B, Bennett S, Connor C, Bekker L-G, et al. PEPFAR under review: what's at stake for PEPFAR's future. Lancet. 2025 Feb 22;405(10479):603–5.

Ratevosian, Jirair, et al. “PEPFAR under review: what's at stake for PEPFAR's future.” Lancet, vol. 405, no. 10479, Feb. 2025, pp. 603–05. Pubmed, doi:10.1016/S0140-6736(25)00258-2.

Ratevosian J, Millett G, Honermann B, Bennett S, Connor C, Bekker L-G, Beyrer C. PEPFAR under review: what's at stake for PEPFAR's future. Lancet. 2025 Feb 22;405(10479):603–605.